Oracle Introduces Agentic Applications with Fusion Claw

Oracle has unveiled its new Fusion Claw platform and expanded its agentic applications, integrating AI reasoning capabilities with enterprise computation. Fusion Claw is designed to allow for highly complex work to be completed more autonomously and at scale.

Customers can leverage Fusion Claw through 25 new agentic applications, which are capable of reasoning, computing, adapting, and executing specialist-grade work. Chris Leone, Oracle's EVP of Applications Development, will discuss how the new offering will enable customers to drive growth and serve their clients.

In related news, Envisagenics has partnered with Boehringer Ingelheim to identify precision cancer targets, aiming to develop therapies for hard-to-treat solid tumors. Envisagenics stated its goal is to transform alternative RNA splicing to engineer a new era of drug discovery.

Market investors are monitoring elevated Treasury yields while awaiting key economic data. The U.S. 10-year Treasury yield closed above 5.2% on Monday. Upcoming economic reports include the August PCE Price Index and the September jobs report, with over 70% of traders anticipating a Fed rate hike in October.